Seelos Therapeutics Inc
NASDAQ:SEEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Seelos Therapeutics Inc
NASDAQ:SEEL
|
US |
|
C
|
Corning Inc
XMUN:GLW
|
US |
|
A
|
Assurant Inc
F:ZAS
|
US |
|
W
|
Wheaton Precious Metals Corp
NYSE:WPM
|
CA |
|
T
|
Toronto-Dominion Bank
XBER:TDB
|
CA |
|
Quadient SA
OTC:NPACY
|
FR |
|
A
|
Abbvie Inc
F:4AB
|
US |
|
B
|
Baltic Classifieds Group PLC
F:983
|
UK |
|
Exelixis Inc
NASDAQ:EXEL
|
US |
|
S
|
Shoprite Holdings Ltd
JSE:SHP
|
ZA |
|
Bonava AB (publ)
LSE:0RHA
|
SE |
|
Okta Inc
NASDAQ:OKTA
|
US |
|
Toray Industries Inc
TSE:3402
|
JP |
|
W
|
Westports Holdings Bhd
KLSE:WPRTS
|
MY |
|
GAIL (India) Ltd
OTC:GAILF
|
IN |
|
Coveo Solutions Inc
TSX:CVO
|
CA |
|
E
|
Elin Electronics Ltd
BSE:543725
|
IN |
|
Life360 Inc
F:L360
|
US |
|
Terex Corp
NYSE:TEX
|
US |
|
Gestamp Automocion SA
MAD:GEST
|
ES |
|
C
|
China Medical System Holdings Ltd
F:2M7C
|
CN |
|
Helmerich and Payne Inc
NYSE:HP
|
US |
|
Meituan
HKEX:3690
|
CN |
|
CVR Energy Inc
NYSE:CVI
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SEEL's stock price target?
Not Available
SEEL does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Seelos Therapeutics Inc?
Projected CAGR
263%
Over the last 8 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 2 years is 263%.